Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

SS Pharm. & Yoshitomi developing triazole antifungal agent

Oct. 4, 1996

BPI-derived fungicidal peptides from Xoma

Oct. 4, 1996

Semisynthetic pneumocandin analogue for fungal infections

Oct. 4, 1996

PathoGenesis selects nitroimidazopyran as potential tuberculosis Rx

Oct. 4, 1996

IntraBiotics' protegrins as potential treatments for multi-drug-resistant infections & gastric ulcer

Oct. 4, 1996

Potential antitubercular agents from PathoGenesis

Oct. 4, 1996

Another series of multifunctional antibacterial agents from P&G

Oct. 4, 1996

Quinolonyl-carbapenems from P&G

Oct. 4, 1996

Orally active ester-type carbapenem prodrug from Sankyo

Oct. 4, 1996

Novel carbapenem with anti-MRSA activity from Banyu

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.